本页面由Tiger Trade Technology Pte. Ltd.提供服务

Armata Pharmaceuticals, Inc.

3.63
0.0000
盘前:3.840.2100+5.79%06:04 EDT
成交量:4.72万
成交额:17.20万
市值:1.35亿
市盈率:-0.69
高:3.84
开:3.65
低:3.56
收:3.63
52周最高:16.34
52周最低:3.14
股本:3,718.20万
流通股本:1,187.54万
量比:0.53
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-5.2744
每股收益(LYR):-4.8000
净资产收益率:-3439.35%
总资产收益率:-25.83%
市净率:-0.58
市盈率(LYR):-0.76

数据加载中...

2020/04/28

重要事件披露

8-K - Current report
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/30

重要事件披露

Current report, items 3.02, 5.03, 5.07, 8.01, and 9.01
2020/03/19

重要事件披露

Current report, items 2.02 and 9.01
2020/03/19

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2020/03/19

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/26

重要事件披露

Current report, items 5.03 and 9.01
2020/02/14

超过5%披露

General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01
2020/01/29

重要事件披露

Current report, items 1.01, 3.02, 8.01, and 9.01
2020/01/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/09

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/20

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/12/11

重要事件披露

Current report, items 5.03, 5.07, and 9.01
2019/11/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/10

重要事件披露

Current report, items 5.02 and 9.01